Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer.

Clinical trial NCT04483505 · COMPLETED

Trial details

NCT number: NCT04483505
Sponsor: Fundacion CRIS de Investigación para Vencer el Cáncer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer Metastatic Hormone Receptor Positive Malignant Neoplasm of Breast

Start date: 2020-11-25
Primary completion: 2023-04-04
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.